Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

8 treatments under study, led by Moviprep

Research Leaders

15 sponsors active, led by Oslo University Hospital

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
Phase 1/2 (1)
Phase 4 (1)

Trial Status

Completed3
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT02504554Phase 1/2CompletedPrimary

Beneficial Bacteria Treatment for Autism

NCT06144905Recruiting

Norwegian Microbiota Study in Anorexia Nervosa

NCT00149968Phase 4Completed

Measurement of Patient Reported Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Renal Transplant Recipients (MyLife)

NCT01177605Not ApplicableCompletedPrimary

Assessment of Efficacy and Tolerance of a Follow-On Milk Containing a Mixture of Prebiotics Fed to Young Children in Salvador, Bahia, Brazil

Showing all 4 trials

Research Network

Common Treatments

  • Moviprep1
  • Entericcoated Mycophenolate Sodium Ecmps1
  • Vancomycin1
  • Standard Care Treatment Program1
  • Prilosec1

Active Sponsors

  • Oslo University Hospital1
  • Counseling on eating disorders, Norway (ROS)1
  • Nordlandssykehuset HF1
  • Modum Bad1
  • University of Arizona1

Top Investigators

Related Conditions

  • Renal Transplantation1
  • Anorexia Nervosa1
  • Autism Spectrum Disorders1
  • Diet1
  • Mental Health Issue1

Activity Timeline